Literature DB >> 21311058

Age-dependent susceptibility to infarct growth in women.

Figen Gokcay1, Ethem Murat Arsava, Tuna Baykaner, Mark Vangel, Priya Garg, Ona Wu, Aneesh B Singhal, Karen L Furie, A Gregory Sorensen, Hakan Ay.   

Abstract

BACKGROUND AND
PURPOSE: It is not known if there is a relationship between gender and tissue outcome in human ischemic stroke. We sought to identify whether the proportion of initially ischemic to eventually infarcted tissue was different between men and women with ischemic stroke.
METHODS: We studied 141 consecutive patients with acute ischemic stroke who had a baseline MRI obtained within 12 hours of symptom onset, a follow-up imaging on Day 4 or later, and diffusion-weighted imaging/mean transmit time mismatch on initial MRI. Lesion growth was calculated as percentage of mismatch tissue that underwent infarction on follow-up (percentage mismatch lost). Multivariable analyses explored the effect of gender and other predictors of tissue outcome on percentage mismatch lost.
RESULTS: There was no difference in median percentage mismatch lost between men (19%) and women (11%; P=0.720). There was, however, an interaction between gender and age; median percentage mismatch lost was 7% (0% to 12%) in women and 18% (1% to 35%) in men younger than the population median (71 years, P=0.061). The percentage mismatch lost was not different between men and women ≥71 years old (25% in both groups). The linear regression model revealed gender (P=0.027) and the interaction between age and gender (P=0.023) as independent predictors of percentage mismatch lost.
CONCLUSIONS: There is an age-by-gender interaction in tissue outcome after ischemic stroke; brain infarcts in women <70 years grow approximately 50% less than infarcts in their male counterparts. These findings extend the well-known concept that there is a differential age-by-gender effect on stroke incidence, mortality, and functional outcome to the tissue level.

Entities:  

Mesh:

Year:  2011        PMID: 21311058      PMCID: PMC3066257          DOI: 10.1161/STROKEAHA.110.603902

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

Review 1.  Oestrogen as a neuroprotective hormone.

Authors:  Christian Behl
Journal:  Nat Rev Neurosci       Date:  2002-06       Impact factor: 34.870

2.  Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke.

Authors:  L D McCullough; N J Alkayed; R J Traystman; M J Williams; P D Hurn
Journal:  Stroke       Date:  2001-03       Impact factor: 7.914

3.  Neuroprotective effects of female gonadal steroids in reproductively senescent female rats.

Authors:  N J Alkayed; S J Murphy; R J Traystman; P D Hurn; V M Miller
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

4.  Histopathological correlations of nuclear magnetic resonance imaging parameters in experimental cerebral ischemia.

Authors:  J A Helpern; M O Dereski; R A Knight; R J Ordidge; M Chopp; Z X Qing
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

5.  Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998.

Authors:  Carma Ayala; Janet B Croft; Kurt J Greenlund; Nora L Keenan; Ralph S Donehoo; Ann M Malarcher; George A Mensah
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

Review 6.  Estrogen and vascular function.

Authors:  Richard E White
Journal:  Vascul Pharmacol       Date:  2002-02       Impact factor: 5.773

7.  Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals.

Authors:  Vanessa L Nordell; M Melissa Scarborough; Angela K Buchanan; Farida Sohrabji
Journal:  Neurobiol Aging       Date:  2003-09       Impact factor: 4.673

8.  Changes in experimental stroke outcome across the life span.

Authors:  Fudong Liu; Rongwen Yuan; Sharon E Benashski; Louise D McCullough
Journal:  J Cereb Blood Flow Metab       Date:  2009-02-18       Impact factor: 6.200

Review 9.  Estrogen and ischemic neuroprotection: an integrated view.

Authors:  Louise D McCullough; Patricia D Hurn
Journal:  Trends Endocrinol Metab       Date:  2003-07       Impact factor: 12.015

10.  Sex differences in postischemic neuronal necrosis in gerbils.

Authors:  E D Hall; K E Pazara; K L Linseman
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

View more
  8 in total

1.  Reduced Ischemic Lesion Growth with Heparin in Acute Ischemic Stroke.

Authors:  Eva A Rocha; Ruijun Ji; Hakan Ay; Zixiao Li; Ethem Murat Arsava; Gisele S Silva; Alma Gregory Sorensen; Ona Wu; Aneesh B Singhal
Journal:  J Stroke Cerebrovasc Dis       Date:  2019-03-29       Impact factor: 2.136

2.  Leukoaraiosis and sex predict the hyperacute ischemic core volume.

Authors:  Nils Henninger; Eugene Lin; Diogo C Haussen; Laura L Lehman; Deepak Takhtani; Magdy Selim; Majaz Moonis
Journal:  Stroke       Date:  2012-12-11       Impact factor: 7.914

3.  Relation of Pre-Stroke Aspirin Use With Cerebral Infarct Volume and Functional Outcomes.

Authors:  Wi-Sun Ryu; Dawid Schellingerhout; Keun-Sik Hong; Sang-Wuk Jeong; Beom Joon Kim; Joon-Tae Kim; Kyung Bok Lee; Tai Hwan Park; Sang-Soon Park; Jong-Moo Park; Kyusik Kang; Yong-Jin Cho; Hong-Kyun Park; Byung-Chul Lee; Kyung-Ho Yu; Mi Sun Oh; Soo Joo Lee; Jae Guk Kim; Jae-Kwan Cha; Dae-Hyun Kim; Jun Lee; Moon-Ku Han; Man Seok Park; Kang-Ho Choi; Matthias Nahrendorf; Juneyoung Lee; Hee-Joon Bae; Dong-Eog Kim
Journal:  Ann Neurol       Date:  2021-10-05       Impact factor: 11.274

4.  Oxidative Stress Biomarkers of Brain Damage: Hyperacute Plasma F2-Isoprostane Predicts Infarct Growth in Stroke.

Authors:  Svetlana Lorenzano; Natalia S Rost; Muhib Khan; Hua Li; Fabricio O Lima; Matthew B Maas; Rebecca E Green; Tijy K Thankachan; Allison J Dipietro; Ken Arai; Angel T Som; Loc-Duyen D Pham; Ona Wu; Gordon J Harris; Eng H Lo; Jeffrey B Blumberg; Paul E Milbury; Steven K Feske; Karen L Furie
Journal:  Stroke       Date:  2018-01-25       Impact factor: 7.914

5.  Sensitivity to acute cerebral ischemic injury in migraineurs: A retrospective case-control study.

Authors:  Jerome Mawet; Katharina Eikermann-Haerter; Kwang-Yeol Park; Johanna Helenius; Ali Daneshmand; Lea Pearlman; Ross Avery; Andrea Negro; Murat Velioglu; Ethem Murat Arsava; Hakan Ay; Cenk Ayata
Journal:  Neurology       Date:  2015-11-04       Impact factor: 9.910

Review 6.  Stem cell therapies in preclinical models of stroke associated with aging.

Authors:  Aurel Popa-Wagner; Ana-Maria Buga; Thorsten R Doeppner; Dirk M Hermann
Journal:  Front Cell Neurosci       Date:  2014-11-03       Impact factor: 5.505

7.  Up-regulation of serotonin receptor 2B mRNA and protein in the peri-infarcted area of aged rats and stroke patients.

Authors:  Ana-Maria Buga; Ovidiu Ciobanu; George Mihai Bădescu; Catalin Bogdan; Ria Weston; Mark Slevin; Mario Di Napoli; Aurel Popa-Wagner
Journal:  Oncotarget       Date:  2016-04-05

8.  Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone.

Authors:  Adrian Tudor Balseanu; Ana-Maria Buga; Bogdan Catalin; Daniel-Christoph Wagner; Johannes Boltze; Ana-Maria Zagrean; Klaus Reymann; Wolf Schaebitz; Aurel Popa-Wagner
Journal:  Front Aging Neurosci       Date:  2014-06-23       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.